APO Research
Talk to an analyst

APO RESEARCH · REPORT

Platinum based Cancer Drug

Platinum-based antineoplastic drugs (informally called platins) are chemotherapeutic agents used to treat cancer. They are coordination complexes of platinum. These drugs are used to treat almost half of people receiving chemotherapy for cancer. In this form of chemotherapy, popular drugs include cisplatin, oxaliplatin, and carboplatin, but several have been proposed or are under development.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Platinum-based antineoplastic drugs (informally called platins) are chemotherapeutic agents used to treat cancer. They are coordination complexes of platinum. These drugs are used to treat almost half of people receiving chemotherapy for cancer. In this form of chemotherapy, popular drugs include cisplatin, oxaliplatin, and carboplatin, but several have been proposed or are under development.

Selected research

Market Analysis & Forecast

Global Platinum based Cancer Drug Market Analysis and Forecast 2026-2032

23 December 2025190 pages

Choose your research edition.

Industry ResearchPlatinum based Cancer Drug Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Platinum based Cancer Drug Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Platinum based Cancer Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Platinum based Cancer Drug Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Platinum based Cancer Drug Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

Platinum-based antineoplastic drugs (informally called platins) are chemotherapeutic agents used to treat cancer. They are coordination complexes of platinum. These drugs are used to treat almost half of people receiving chemotherapy for cancer. In this form of chemotherapy, popular drugs include cisplatin, oxaliplatin, and carboplatin, but several have been proposed or are under development.

The classification of platinum based cancer drug includes cisplatin, oxaliplatin, carboplatin and other types. The proportion of oxaliplatin is about 71%.

Platinum based cancer drug is widely used for colorectal cancer, ovarian cancer, lung cancer and other cancer. The most proportion of platinum based cancer drug is for colorectal cancer, and the proportion is about 62%.

Read the full market overview

Asia-Pacific is the largest market, with a sales market share nearly 53%. Following Asia-Pacific, Europe is the second largest sales place with the sales market share of 17%.

Market competition is intense. Sanofi, Hengrui Medicine, ASK Pharma, Yi Bai Pharmaceutical, Qilu Pharmaceutical and Teva, etc. are the leaders of the industry, with about 42% market shares.

This report presents an overview of global market for Platinum based Cancer Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Platinum based Cancer Drug, also provides the sales of main regions and countries. Of the upcoming market potential for Platinum based Cancer Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Platinum based Cancer Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Platinum based Cancer Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Platinum based Cancer Drug sales, projected growth trends, production technology, application and end-user industry.

Platinum based Cancer Drug Segment by Company

Sanofi

Hengrui Medicine

ASK Pharma

Yi Bai Pharmaceutical

Qilu Pharmaceutical

Teva

Pfizer

Dr Reddy's Laboratories

Mylan

Sun Pharma

Novartis

Debiopharm

Accord Healthcare

SK Chemicals

Platinum based Cancer Drug Segment by Type

Cisplatin

Oxaliplatin

Carboplatin

Others

Platinum based Cancer Drug Segment by Application

Colorectal Cancer

Ovarian Cancer

Lung Cancer

Others

Platinum based Cancer Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Platinum based Cancer Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Platinum based Cancer Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Platinum based Cancer Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Platinum based Cancer Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Platinum based Cancer Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Platinum based Cancer Drug sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Platinum based Cancer Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Cisplatin Major Manufacturers Table 3. Oxaliplatin Major Manufacturers Table 4. Carboplatin Major Manufacturers Table 5. Others Major Manufacturers Table 6. Global Platinum based Cancer Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Colorectal Cancer Major Manufacturers Table 8. Ovarian Cancer Major Manufacturers Table 9. Lung Cancer Major Manufacturers Table 10. Others Major Manufacturers Table 11. Platinum based Cancer Drug Industry Trends Table 12. Platinum based Cancer Drug Industry Drivers Table 13. Platinum based Cancer Drug Industry Opportunities and Challenges Table 14. Platinum based Cancer Drug Industry Restraints Table 15. Global Platinum based Cancer Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global Platinum based Cancer Drug Revenue by Region (2021-2026) & (US$ Million) Table 17. Global Platinum based Cancer Drug Revenue by Region (2027-2032) & (US$ Million) Table 18. Global Platinum based Cancer Drug Revenue Market Share by Region (2021-2026) Table 19. Global Platinum based Cancer Drug Revenue Market Share by Region (2027-2032) Table 20. Global Platinum based Cancer Drug Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 21. Global Platinum based Cancer Drug Sales by Region (2021-2026) & (K Units) Table 22. Global Platinum based Cancer Drug Sales by Region (2027-2032) & (K Units) Table 23. Global Platinum based Cancer Drug Sales Market Share by Region (2021-2026) Table 24. Global Platinum based Cancer Drug Sales Market Share by Region (2027-2032) Table 25. Global Platinum based Cancer Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Platinum based Cancer Drug Revenue Market Share by Manufacturers (2021-2026) Table 27. Global Platinum based Cancer Drug Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Platinum based Cancer Drug Sales Market Share by Manufacturers (2021-2026) Table 29. Global Platinum based Cancer Drug Sales Price (USD/Unit) of Manufacturers (2021-2026) Table 30. Global Platinum based Cancer Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global Platinum based Cancer Drug Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global Platinum based Cancer Drug Manufacturers, Product Type & Application Table 33. Global Platinum based Cancer Drug Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global Platinum based Cancer Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global Platinum based Cancer Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Platinum based Cancer Drug Revenue by Type (2021-2026) & (US$ Million) Table 38. Global Platinum based Cancer Drug Revenue by Type (2027-2032) & (US$ Million) Table 39. Global Platinum based Cancer Drug Revenue Market Share by Type (2021-2026) Table 40. Global Platinum based Cancer Drug Revenue Market Share by Type (2027-2032) Table 41. Global Platinum based Cancer Drug Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 42. Global Platinum based Cancer Drug Sales by Type (2021-2026) & (K Units) Table 43. Global Platinum based Cancer Drug Sales by Type (2027-2032) & (K Units) Table 44. Global Platinum based Cancer Drug Sales Market Share by Type (2021-2026) Table 45. Global Platinum based Cancer Drug Sales Market Share by Type (2027-2032) Table 46. Global Platinum based Cancer Drug Price by Type (2021-2026) & (USD/Unit) Table 47. Global Platinum based Cancer Drug Price by Type (2027-2032) & (USD/Unit) Table 48. Global Platinum based Cancer Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Platinum based Cancer Drug Revenue by Application (2021-2026) & (US$ Million) Table 50. Global Platinum based Cancer Drug Revenue by Application (2027-2032) & (US$ Million) Table 51. Global Platinum based Cancer Drug Revenue Market Share by Application (2021-2026) Table 52. Global Platinum based Cancer Drug Revenue Market Share by Application (2027-2032) Table 53. Global Platinum based Cancer Drug Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 54. Global Platinum based Cancer Drug Sales by Application (2021-2026) & (K Units) Table 55. Global Platinum based Cancer Drug Sales by Application (2027-2032) & (K Units) Table 56. Global Platinum based Cancer Drug Sales Market Share by Application (2021-2026) Table 57. Global Platinum based Cancer Drug Sales Market Share by Application (2027-2032) Table 58. Global Platinum based Cancer Drug Price by Application (2021-2026) & (USD/Unit) Table 59. Global Platinum based Cancer Drug Price by Application (2027-2032) & (USD/Unit) Table 60. Sanofi Company Information Table 61. Sanofi Business Overview Table 62. Sanofi Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 63. Sanofi Platinum based Cancer Drug Product Portfolio Table 64. Sanofi Recent Development Table 65. Hengrui Medicine Company Information Table 66. Hengrui Medicine Business Overview Table 67. Hengrui Medicine Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 68. Hengrui Medicine Platinum based Cancer Drug Product Portfolio Table 69. Hengrui Medicine Recent Development Table 70. ASK Pharma Company Information Table 71. ASK Pharma Business Overview Table 72. ASK Pharma Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 73. ASK Pharma Platinum based Cancer Drug Product Portfolio Table 74. ASK Pharma Recent Development Table 75. Yi Bai Pharmaceutical Company Information Table 76. Yi Bai Pharmaceutical Business Overview Table 77. Yi Bai Pharmaceutical Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 78. Yi Bai Pharmaceutical Platinum based Cancer Drug Product Portfolio Table 79. Yi Bai Pharmaceutical Recent Development Table 80. Qilu Pharmaceutical Company Information Table 81. Qilu Pharmaceutical Business Overview Table 82. Qilu Pharmaceutical Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 83. Qilu Pharmaceutical Platinum based Cancer Drug Product Portfolio Table 84. Qilu Pharmaceutical Recent Development Table 85. Teva Company Information Table 86. Teva Business Overview Table 87. Teva Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 88. Teva Platinum based Cancer Drug Product Portfolio Table 89. Teva Recent Development Table 90. Pfizer Company Information Table 91. Pfizer Business Overview Table 92. Pfizer Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 93. Pfizer Platinum based Cancer Drug Product Portfolio Table 94. Pfizer Recent Development Table 95. Dr Reddy's Laboratories Company Information Table 96. Dr Reddy's Laboratories Business Overview Table 97. Dr Reddy's Laboratories Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 98. Dr Reddy's Laboratories Platinum based Cancer Drug Product Portfolio Table 99. Dr Reddy's Laboratories Recent Development Table 100. Mylan Company Information Table 101. Mylan Business Overview Table 102. Mylan Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 103. Mylan Platinum based Cancer Drug Product Portfolio Table 104. Mylan Recent Development Table 105. Sun Pharma Company Information Table 106. Sun Pharma Business Overview Table 107. Sun Pharma Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 108. Sun Pharma Platinum based Cancer Drug Product Portfolio Table 109. Sun Pharma Recent Development Table 110. Novartis Company Information Table 111. Novartis Business Overview Table 112. Novartis Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 113. Novartis Platinum based Cancer Drug Product Portfolio Table 114. Novartis Recent Development Table 115. Debiopharm Company Information Table 116. Debiopharm Business Overview Table 117. Debiopharm Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 118. Debiopharm Platinum based Cancer Drug Product Portfolio Table 119. Debiopharm Recent Development Table 120. Accord Healthcare Company Information Table 121. Accord Healthcare Business Overview Table 122. Accord Healthcare Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 123. Accord Healthcare Platinum based Cancer Drug Product Portfolio Table 124. Accord Healthcare Recent Development Table 125. SK Chemicals Company Information Table 126. SK Chemicals Business Overview Table 127. SK Chemicals Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 128. SK Chemicals Platinum based Cancer Drug Product Portfolio Table 129. SK Chemicals Recent Development Table 130. North America Platinum based Cancer Drug Revenue by Type (2021-2026) & (US$ Million) Table 131. North America Platinum based Cancer Drug Revenue by Type (2027-2032) & (US$ Million) Table 132. North America Platinum based Cancer Drug Sales by Type (2021-2026) & (K Units) Table 133. North America Platinum based Cancer Drug Sales by Type (2027-2032) & (K Units) Table 134. North America Platinum based Cancer Drug Sales Price by Type (2021-2026) & (USD/Unit) Table 135. North America Platinum based Cancer Drug Sales Price by Type (2027-2032) & (USD/Unit) Table 136. North America Platinum based Cancer Drug Revenue by Application (2021-2026) & (US$ Million) Table 137. North America Platinum based Cancer Drug Revenue by Application (2027-2032) & (US$ Million) Table 138. North America Platinum based Cancer Drug Sales by Application (2021-2026) & (K Units) Table 139. North America Platinum based Cancer Drug Sales by Application (2027-2032) & (K Units) Table 140. North America Platinum based Cancer Drug Sales Price by Application (2021-2026) & (USD/Unit) Table 141. North America Platinum based Cancer Drug Sales Price by Application (2027-2032) & (USD/Unit) Table 142. North America Platinum based Cancer Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 143. North America Platinum based Cancer Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 144. North America Platinum based Cancer Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 145. North America Platinum based Cancer Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 146. North America Platinum based Cancer Drug Sales by Country (2021-2026) & (K Units) Table 147. North America Platinum based Cancer Drug Sales by Country (2027-2032) & (K Units) Table 148. North America Platinum based Cancer Drug Sales Price by Country (2021-2026) & (USD/Unit) Table 149. North America Platinum based Cancer Drug Sales Price by Country (2027-2032) & (USD/Unit) Table 150. United States Platinum based Cancer Drug Revenue (2021-2032) & (US$ Million) Table 151. Canada Platinum based Cancer Drug Revenue (2021-2032) & (US$ Million) Table 152. Mexico Platinum based Cancer Drug Revenue (2021-2032) & (US$ Million) Table 153. Europe Platinum based Cancer Drug Revenue by Type (2021-2026) & (US$ Million) Table 154. Europe Platinum based Cancer Drug Revenue by Type (2027-2032) & (US$ Million) Table 155. Europe Platinum based Cancer Drug Sales by Type (2021-2026) & (K Units) Table 156. Europe Platinum based Cancer Drug Sales by Type (2027-2032) & (K Units) Table 157. Europe Platinum based Cancer Drug Sales Price by Type (2021-2026) & (USD/Unit) Table 158. Europe Platinum based Cancer Drug Sales Price by Type (2027-2032) & (USD/Unit) Table 159. Europe Platinum based Cancer Drug Revenue by Application (2021-2026) & (US$ Million) Table 160. Europe Platinum based Cancer Drug Revenue by Application (2027-2032) & (US$ Million) Table 161. Europe Platinum based Cancer Drug Sales by Application (2021-2026) & (K Units) Table 162. Europe Platinum based Cancer Drug Sales by Application (2027-2032) & (K Units) Table 163. Europe Platinum based Cancer Drug Sales Price by Application (2021-2026) & (USD/Unit) Table 164. Europe Platinum based Cancer Drug Sales Price by Application (2027-2032) & (USD/Unit) Table 165. Europe Platinum based Cancer Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 166. Europe Platinum based Cancer Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 167. Europe Platinum based Cancer Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 168. Europe Platinum based Cancer Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 169. Europe Platinum based Cancer Drug Sales by Country (2021-2026) & (K Units) Table 170. Europe Platinum based Cancer Drug Sales by Country (2027-2032) & (K Units) Table 171. Europe Platinum based Cancer Drug Sales Price by Country (2021-2026) & (USD/Unit) Table 172. Europe Platinum based Cancer Drug Sales Price by Country (2027-2032) & (USD/Unit) Table 173. Germany Platinum based Cancer Drug Revenue (2021-2032) & (US$ Million) Table 174. France Platinum based Cancer Drug Revenue (2021-2032) & (US$ Million) Table 175. U.K. Platinum based Cancer Drug Revenue (2021-2032) & (US$ Million) Table 176. Italy Platinum based Cancer Drug Revenue (2021-2032) & (US$ Million) Table 177. Russia Platinum based Cancer Drug Revenue (2021-2032) & (US$ Million) Table 178. Spain Platinum based Cancer Drug Revenue (2021-2032) & (US$ Million) Table 179. Netherlands Platinum based Cancer Drug Revenue (2021-2032) & (US$ Million) Table 180. Switzerland Platinum based Cancer Drug Revenue (2021-2032) & (US$ Million) Table 181. Sweden Platinum based Cancer Drug Revenue (2021-2032) & (US$ Million) Table 182. Poland Platinum based Cancer Drug Revenue (2021-2032) & (US$ Million) Table 183. China Platinum based Cancer Drug Revenue by Type (2021-2026) & (US$ Million) Table 184. China Platinum based Cancer Drug Revenue by Type (2027-2032) & (US$ Million) Table 185. China Platinum based Cancer Drug Sales by Type (2021-2026) & (K Units) Table 186. China Platinum based Cancer Drug Sales by Type (2027-2032) & (K Units) Table 187. China Platinum based Cancer Drug Sales Price by Type (2021-2026) & (USD/Unit) Table 188. China Platinum based Cancer Drug Sales Price by Type (2027-2032) & (USD/Unit) Table 189. China Platinum based Cancer Drug Revenue by Application (2021-2026) & (US$ Million) Table 190. China Platinum based Cancer Drug Revenue by Application (2027-2032) & (US$ Million) Table 191. China Platinum based Cancer Drug Sales by Application (2021-2026) & (K Units) Table 192. China Platinum based Cancer Drug Sales by Application (2027-2032) & (K Units) Table 193. China Platinum based Cancer Drug Sales Price by Application (2021-2026) & (USD/Unit) Table 194. China Platinum based Cancer Drug Sales Price by Application (2027-2032) & (USD/Unit) Table 195. Asia Platinum based Cancer Drug Revenue by Type (2021-2026) & (US$ Million) Table 196. Asia Platinum based Cancer Drug Revenue by Type (2027-2032) & (US$ Million) Table 197. Asia Platinum based Cancer Drug Sales by Type (2021-2026) & (K Units) Table 198. Asia Platinum based Cancer Drug Sales by Type (2027-2032) & (K Units) Table 199. Asia Platinum based Cancer Drug Sales Price by Type (2021-2026) & (USD/Unit) Table 200. Asia Platinum based Cancer Drug Sales Price by Type (2027-2032) & (USD/Unit) Table 201. Asia Platinum based Cancer Drug Revenue by Application (2021-2026) & (US$ Million) Table 202. Asia Platinum based Cancer Drug Revenue by Application (2027-2032) & (US$ Million) Table 203. Asia Platinum based Cancer Drug Sales by Application (2021-2026) & (K Units) Table 204. Asia Platinum based Cancer Drug Sales by Application (2027-2032) & (K Units) Table 205. Asia Platinum based Cancer Drug Sales Price by Application (2021-2026) & (USD/Unit) Table 206. Asia Platinum based Cancer Drug Sales Price by Application (2027-2032) & (USD/Unit) Table 207. Asia Platinum based Cancer Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 208. Asia Platinum based Cancer Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 209. Asia Platinum based Cancer Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 210. Asia Platinum based Cancer Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 211. Asia Platinum based Cancer Drug Sales by Country (2021-2026) & (K Units) Table 212. Asia Platinum based Cancer Drug Sales by Country (2027-2032) & (K Units) Table 213. Asia Platinum based Cancer Drug Sales Price by Country (2021-2026) & (USD/Unit) Table 214. Asia Platinum based Cancer Drug Sales Price by Country (2027-2032) & (USD/Unit) Table 215. Japan Platinum based Cancer Drug Revenue (2021-2032) & (US$ Million) Table 216. South Korea Platinum based Cancer Drug Revenue (2021-2032) & (US$ Million) Table 217. India Platinum based Cancer Drug Revenue (2021-2032) & (US$ Million) Table 218. Australia Platinum based Cancer Drug Revenue (2021-2032) & (US$ Million) Table 219. Taiwan Platinum based Cancer Drug Revenue (2021-2032) & (US$ Million) Table 220. Southeast Asia Platinum based Cancer Drug Revenue (2021-2032) & (US$ Million) Table 221. SAMEA Platinum based Cancer Drug Revenue by Type (2021-2026) & (US$ Million) Table 222. SAMEA Platinum based Cancer Drug Revenue by Type (2027-2032) & (US$ Million) Table 223. SAMEA Platinum based Cancer Drug Sales by Type (2021-2026) & (K Units) Table 224. SAMEA Platinum based Cancer Drug Sales by Type (2027-2032) & (K Units) Table 225. SAMEA Platinum based Cancer Drug Sales Price by Type (2021-2026) & (USD/Unit) Table 226. SAMEA Platinum based Cancer Drug Sales Price by Type (2027-2032) & (USD/Unit) Table 227. SAMEA Platinum based Cancer Drug Revenue by Application (2021-2026) & (US$ Million) Table 228. SAMEA Platinum based Cancer Drug Revenue by Application (2027-2032) & (US$ Million) Table 229. SAMEA Platinum based Cancer Drug Sales by Application (2021-2026) & (K Units) Table 230. SAMEA Platinum based Cancer Drug Sales by Application (2027-2032) & (K Units) Table 231. SAMEA Platinum based Cancer Drug Sales Price by Application (2021-2026) & (USD/Unit) Table 232. SAMEA Platinum based Cancer Drug Sales Price by Application (2027-2032) & (USD/Unit) Table 233. SAMEA Platinum based Cancer Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 234. SAMEA Platinum based Cancer Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 235. SAMEA Platinum based Cancer Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 236. SAMEA Platinum based Cancer Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 237. SAMEA Platinum based Cancer Drug Sales by Country (2021-2026) & (K Units) Table 238. SAMEA Platinum based Cancer Drug Sales by Country (2027-2032) & (K Units) Table 239. SAMEA Platinum based Cancer Drug Sales Price by Country (2021-2026) & (USD/Unit) Table 240. SAMEA Platinum based Cancer Drug Sales Price by Country (2027-2032) & (USD/Unit) Table 241. Brazil Platinum based Cancer Drug Revenue (2021-2032) & (US$ Million) Table 242. Argentina Platinum based Cancer Drug Revenue (2021-2032) & (US$ Million) Table 243. Chile Platinum based Cancer Drug Revenue (2021-2032) & (US$ Million) Table 244. Colombia Platinum based Cancer Drug Revenue (2021-2032) & (US$ Million) Table 245. Peru Platinum based Cancer Drug Revenue (2021-2032) & (US$ Million) Table 246. Saudi Arabia Platinum based Cancer Drug Revenue (2021-2032) & (US$ Million) Table 247. Israel Platinum based Cancer Drug Revenue (2021-2032) & (US$ Million) Table 248. UAE Platinum based Cancer Drug Revenue (2021-2032) & (US$ Million) Table 249. Turkey Platinum based Cancer Drug Revenue (2021-2032) & (US$ Million) Table 250. Iran Platinum based Cancer Drug Revenue (2021-2032) & (US$ Million) Table 251. Egypt Platinum based Cancer Drug Revenue (2021-2032) & (US$ Million) Table 252. Key Raw Materials Table 253. Raw Materials Key Suppliers Table 254. Platinum based Cancer Drug Distributors List Table 255. Platinum based Cancer Drug Customers List Table 256. Research Programs/Design for This Report Table 257. Authors List of This Report Table 258. Secondary Sources Table 259. Primary Sources List of Figures Figure 1. Platinum based Cancer Drug Image Figure 2. Global Platinum based Cancer Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Platinum based Cancer Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. Cisplatin Image Figure 5. Oxaliplatin Image Figure 6. Carboplatin Image Figure 7. Others Image Figure 8. Global Platinum based Cancer Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Platinum based Cancer Drug Market Size Share 2021 VS 2025 VS 2032 Figure 10. Colorectal Cancer Image Figure 11. Ovarian Cancer Image Figure 12. Lung Cancer Image Figure 13. Others Image Figure 14. Global Platinum based Cancer Drug Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Platinum based Cancer Drug Revenue (2021-2032) & (US$ Million) Figure 16. Global Platinum based Cancer Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global Platinum based Cancer Drug Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global Platinum based Cancer Drug Revenue Market Share by Region (2021-2032) Figure 19. Global Platinum based Cancer Drug Sales (2021-2032) & (K Units) Figure 20. Global Platinum based Cancer Drug Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 21. Global Platinum based Cancer Drug Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico Platinum based Cancer Drug Sales YoY (2021-2032) & (K Units) Figure 23. Europe Platinum based Cancer Drug Sales YoY (2021-2032) & (K Units) Figure 24. China Platinum based Cancer Drug Sales YoY (2021-2032) & (K Units) Figure 25. Asia (Excluding China) Platinum based Cancer Drug Sales YoY (2021-2032) & (K Units) Figure 26. South America, Middle East and Africa Platinum based Cancer Drug Sales YoY (2021-2032) & (K Units) Figure 27. Global Platinum based Cancer Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global Platinum based Cancer Drug Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global Platinum based Cancer Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Platinum based Cancer Drug Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Platinum based Cancer Drug Revenue Market Share by Type (2021-2032) Figure 33. Global Platinum based Cancer Drug Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 34. Global Platinum based Cancer Drug Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Platinum based Cancer Drug Sales Market Share by Type (2021-2032) Figure 36. Global Platinum based Cancer Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global Platinum based Cancer Drug Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Platinum based Cancer Drug Revenue Market Share by Application (2021-2032) Figure 39. Global Platinum based Cancer Drug Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 40. Global Platinum based Cancer Drug Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Platinum based Cancer Drug Sales Market Share by Application (2021-2032) Figure 42. North America Platinum based Cancer Drug Revenue Share by Type (2021-2032) Figure 43. North America Platinum based Cancer Drug Sales Share by Type (2021-2032) Figure 44. North America Platinum based Cancer Drug Revenue Share by Application (2021-2032) Figure 45. North America Platinum based Cancer Drug Sales Share by Application (2021-2032) Figure 46. North America Platinum based Cancer Drug Revenue Share by Country (2021-2032) Figure 47. North America Platinum based Cancer Drug Sales Share by Country (2021-2032) Figure 48. Europe Platinum based Cancer Drug Revenue Share by Type (2021-2032) Figure 49. Europe Platinum based Cancer Drug Sales Share by Type (2021-2032) Figure 50. Europe Platinum based Cancer Drug Revenue Share by Application (2021-2032) Figure 51. Europe Platinum based Cancer Drug Sales Share by Application (2021-2032) Figure 52. Europe Platinum based Cancer Drug Revenue Share by Country (2021-2032) Figure 53. Europe Platinum based Cancer Drug Sales Share by Country (2021-2032) Figure 54. China Platinum based Cancer Drug Revenue Share by Type (2021-2032) Figure 55. China Platinum based Cancer Drug Sales Share by Type (2021-2032) Figure 56. China Platinum based Cancer Drug Revenue Share by Application (2021-2032) Figure 57. China Platinum based Cancer Drug Sales Share by Application (2021-2032) Figure 58. Asia Platinum based Cancer Drug Revenue Share by Type (2021-2032) Figure 59. Asia Platinum based Cancer Drug Sales Share by Type (2021-2032) Figure 60. Asia Platinum based Cancer Drug Revenue Share by Application (2021-2032) Figure 61. Asia Platinum based Cancer Drug Sales Share by Application (2021-2032) Figure 62. Asia Platinum based Cancer Drug Revenue Share by Country (2021-2032) Figure 63. Asia Platinum based Cancer Drug Sales Share by Country (2021-2032) Figure 64. SAMEA Platinum based Cancer Drug Revenue Share by Type (2021-2032) Figure 65. SAMEA Platinum based Cancer Drug Sales Share by Type (2021-2032) Figure 66. SAMEA Platinum based Cancer Drug Revenue Share by Application (2021-2032) Figure 67. SAMEA Platinum based Cancer Drug Sales Share by Application (2021-2032) Figure 68. SAMEA Platinum based Cancer Drug Revenue Share by Country (2021-2032) Figure 69. SAMEA Platinum based Cancer Drug Sales Share by Country (2021-2032) Figure 70. Platinum based Cancer Drug Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Platinum based Cancer Drug Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Cisplatin
  • Oxaliplatin
  • Carboplatin
  • Others
Applications
  • Colorectal Cancer
  • Ovarian Cancer
  • Lung Cancer
  • Others
Companies covered
  • Sanofi
  • Hengrui Medicine
  • ASK Pharma
  • Yi Bai Pharmaceutical
  • Qilu Pharmaceutical
  • Teva
  • Pfizer
  • Dr Reddy's Laboratories
  • Mylan
  • Sun Pharma
  • Novartis
  • Debiopharm
  • Accord Healthcare
  • SK Chemicals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Platinum based Cancer Drug Market by Type
  3. 1.2.1 Global Platinum based Cancer Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Cisplatin
  5. 1.2.3 Oxaliplatin
  6. 1.2.4 Carboplatin
  7. 1.2.5 Others
  8. 1.3 Platinum based Cancer Drug Market by Application
  9. 1.3.1 Global Platinum based Cancer Drug Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Colorectal Cancer
  11. 1.3.3 Ovarian Cancer
  12. 1.3.4 Lung Cancer
  13. 1.3.5 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Platinum based Cancer Drug Market Dynamics
  1. 2.1 Platinum based Cancer Drug Industry Trends
  2. 2.2 Platinum based Cancer Drug Industry Drivers
  3. 2.3 Platinum based Cancer Drug Industry Opportunities and Challenges
  4. 2.4 Platinum based Cancer Drug Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Platinum based Cancer Drug Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Platinum based Cancer Drug Revenue by Region
  3. 3.2.1 Global Platinum based Cancer Drug Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Platinum based Cancer Drug Revenue by Region (2021-2026)
  5. 3.2.3 Global Platinum based Cancer Drug Revenue by Region (2027-2032)
  6. 3.2.4 Global Platinum based Cancer Drug Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Platinum based Cancer Drug Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Platinum based Cancer Drug Sales by Region
  9. 3.4.1 Global Platinum based Cancer Drug Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Platinum based Cancer Drug Sales by Region (2021-2026)
  11. 3.4.3 Global Platinum based Cancer Drug Sales by Region (2027-2032)
  12. 3.4.4 Global Platinum based Cancer Drug Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Platinum based Cancer Drug Revenue by Manufacturers
  2. 4.1.1 Global Platinum based Cancer Drug Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Platinum based Cancer Drug Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Platinum based Cancer Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Platinum based Cancer Drug Sales by Manufacturers
  6. 4.2.1 Global Platinum based Cancer Drug Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Platinum based Cancer Drug Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Platinum based Cancer Drug Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Platinum based Cancer Drug Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Platinum based Cancer Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Platinum based Cancer Drug Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Platinum based Cancer Drug Manufacturers, Product Type & Application
  13. 4.7 Global Platinum based Cancer Drug Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Platinum based Cancer Drug Market CR5 and HHI
  16. 4.8.2 2025 Platinum based Cancer Drug Tier 1, Tier 2, and Tier 3
5 Platinum based Cancer Drug Market by Type
  1. 5.1 Global Platinum based Cancer Drug Revenue by Type
  2. 5.1.1 Global Platinum based Cancer Drug Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Platinum based Cancer Drug Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Platinum based Cancer Drug Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Platinum based Cancer Drug Sales by Type
  6. 5.2.1 Global Platinum based Cancer Drug Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Platinum based Cancer Drug Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Platinum based Cancer Drug Sales Market Share by Type (2021-2032)
  9. 5.3 Global Platinum based Cancer Drug Price by Type
6 Platinum based Cancer Drug Market by Application
  1. 6.1 Global Platinum based Cancer Drug Revenue by Application
  2. 6.1.1 Global Platinum based Cancer Drug Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Platinum based Cancer Drug Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Platinum based Cancer Drug Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Platinum based Cancer Drug Sales by Application
  6. 6.2.1 Global Platinum based Cancer Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Platinum based Cancer Drug Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Platinum based Cancer Drug Sales Market Share by Application (2021-2032)
  9. 6.3 Global Platinum based Cancer Drug Price by Application
7 Company Profiles
  1. 7.1 Sanofi
  2. 7.1.1 Sanofi Company Information
  3. 7.1.2 Sanofi Business Overview
  4. 7.1.3 Sanofi Platinum based Cancer Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Sanofi Platinum based Cancer Drug Product Portfolio
  6. 7.1.5 Sanofi Recent Developments
  7. 7.2 Hengrui Medicine
  8. 7.2.1 Hengrui Medicine Company Information
  9. 7.2.2 Hengrui Medicine Business Overview
  10. 7.2.3 Hengrui Medicine Platinum based Cancer Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Hengrui Medicine Platinum based Cancer Drug Product Portfolio
  12. 7.2.5 Hengrui Medicine Recent Developments
  13. 7.3 ASK Pharma
  14. 7.3.1 ASK Pharma Company Information
  15. 7.3.2 ASK Pharma Business Overview
  16. 7.3.3 ASK Pharma Platinum based Cancer Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 ASK Pharma Platinum based Cancer Drug Product Portfolio
  18. 7.3.5 ASK Pharma Recent Developments
  19. 7.4 Yi Bai Pharmaceutical
  20. 7.4.1 Yi Bai Pharmaceutical Company Information
  21. 7.4.2 Yi Bai Pharmaceutical Business Overview
  22. 7.4.3 Yi Bai Pharmaceutical Platinum based Cancer Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Yi Bai Pharmaceutical Platinum based Cancer Drug Product Portfolio
  24. 7.4.5 Yi Bai Pharmaceutical Recent Developments
  25. 7.5 Qilu Pharmaceutical
  26. 7.5.1 Qilu Pharmaceutical Company Information
  27. 7.5.2 Qilu Pharmaceutical Business Overview
  28. 7.5.3 Qilu Pharmaceutical Platinum based Cancer Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Qilu Pharmaceutical Platinum based Cancer Drug Product Portfolio
  30. 7.5.5 Qilu Pharmaceutical Recent Developments
  31. 7.6 Teva
  32. 7.6.1 Teva Company Information
  33. 7.6.2 Teva Business Overview
  34. 7.6.3 Teva Platinum based Cancer Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Teva Platinum based Cancer Drug Product Portfolio
  36. 7.6.5 Teva Recent Developments
  37. 7.7 Pfizer
  38. 7.7.1 Pfizer Company Information
  39. 7.7.2 Pfizer Business Overview
  40. 7.7.3 Pfizer Platinum based Cancer Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Pfizer Platinum based Cancer Drug Product Portfolio
  42. 7.7.5 Pfizer Recent Developments
  43. 7.8 Dr Reddy's Laboratories
  44. 7.8.1 Dr Reddy's Laboratories Company Information
  45. 7.8.2 Dr Reddy's Laboratories Business Overview
  46. 7.8.3 Dr Reddy's Laboratories Platinum based Cancer Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Dr Reddy's Laboratories Platinum based Cancer Drug Product Portfolio
  48. 7.8.5 Dr Reddy's Laboratories Recent Developments
  49. 7.9 Mylan
  50. 7.9.1 Mylan Company Information
  51. 7.9.2 Mylan Business Overview
  52. 7.9.3 Mylan Platinum based Cancer Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Mylan Platinum based Cancer Drug Product Portfolio
  54. 7.9.5 Mylan Recent Developments
  55. 7.10 Sun Pharma
  56. 7.10.1 Sun Pharma Company Information
  57. 7.10.2 Sun Pharma Business Overview
  58. 7.10.3 Sun Pharma Platinum based Cancer Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Sun Pharma Platinum based Cancer Drug Product Portfolio
  60. 7.10.5 Sun Pharma Recent Developments
  61. 7.11 Novartis
  62. 7.11.1 Novartis Company Information
  63. 7.11.2 Novartis Business Overview
  64. 7.11.3 Novartis Platinum based Cancer Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Novartis Platinum based Cancer Drug Product Portfolio
  66. 7.11.5 Novartis Recent Developments
  67. 7.12 Debiopharm
  68. 7.12.1 Debiopharm Company Information
  69. 7.12.2 Debiopharm Business Overview
  70. 7.12.3 Debiopharm Platinum based Cancer Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Debiopharm Platinum based Cancer Drug Product Portfolio
  72. 7.12.5 Debiopharm Recent Developments
  73. 7.13 Accord Healthcare
  74. 7.13.1 Accord Healthcare Company Information
  75. 7.13.2 Accord Healthcare Business Overview
  76. 7.13.3 Accord Healthcare Platinum based Cancer Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Accord Healthcare Platinum based Cancer Drug Product Portfolio
  78. 7.13.5 Accord Healthcare Recent Developments
  79. 7.14 SK Chemicals
  80. 7.14.1 SK Chemicals Company Information
  81. 7.14.2 SK Chemicals Business Overview
  82. 7.14.3 SK Chemicals Platinum based Cancer Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 SK Chemicals Platinum based Cancer Drug Product Portfolio
  84. 7.14.5 SK Chemicals Recent Developments
8 North America
  1. 8.1 North America Platinum based Cancer Drug Market Size by Type
  2. 8.1.1 North America Platinum based Cancer Drug Revenue by Type (2021-2032)
  3. 8.1.2 North America Platinum based Cancer Drug Sales by Type (2021-2032)
  4. 8.1.3 North America Platinum based Cancer Drug Price by Type (2021-2032)
  5. 8.2 North America Platinum based Cancer Drug Market Size by Application
  6. 8.2.1 North America Platinum based Cancer Drug Revenue by Application (2021-2032)
  7. 8.2.2 North America Platinum based Cancer Drug Sales by Application (2021-2032)
  8. 8.2.3 North America Platinum based Cancer Drug Price by Application (2021-2032)
  9. 8.3 North America Platinum based Cancer Drug Market Size by Country
  10. 8.3.1 North America Platinum based Cancer Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Platinum based Cancer Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Platinum based Cancer Drug Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Platinum based Cancer Drug Market Size by Type
  2. 9.1.1 Europe Platinum based Cancer Drug Revenue by Type (2021-2032)
  3. 9.1.2 Europe Platinum based Cancer Drug Sales by Type (2021-2032)
  4. 9.1.3 Europe Platinum based Cancer Drug Price by Type (2021-2032)
  5. 9.2 Europe Platinum based Cancer Drug Market Size by Application
  6. 9.2.1 Europe Platinum based Cancer Drug Revenue by Application (2021-2032)
  7. 9.2.2 Europe Platinum based Cancer Drug Sales by Application (2021-2032)
  8. 9.2.3 Europe Platinum based Cancer Drug Price by Application (2021-2032)
  9. 9.3 Europe Platinum based Cancer Drug Market Size by Country
  10. 9.3.1 Europe Platinum based Cancer Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Platinum based Cancer Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Platinum based Cancer Drug Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Platinum based Cancer Drug Market Size by Type
  2. 10.1.1 China Platinum based Cancer Drug Revenue by Type (2021-2032)
  3. 10.1.2 China Platinum based Cancer Drug Sales by Type (2021-2032)
  4. 10.1.3 China Platinum based Cancer Drug Price by Type (2021-2032)
  5. 10.2 China Platinum based Cancer Drug Market Size by Application
  6. 10.2.1 China Platinum based Cancer Drug Revenue by Application (2021-2032)
  7. 10.2.2 China Platinum based Cancer Drug Sales by Application (2021-2032)
  8. 10.2.3 China Platinum based Cancer Drug Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Platinum based Cancer Drug Market Size by Type
  2. 11.1.1 Asia Platinum based Cancer Drug Revenue by Type (2021-2032)
  3. 11.1.2 Asia Platinum based Cancer Drug Sales by Type (2021-2032)
  4. 11.1.3 Asia Platinum based Cancer Drug Price by Type (2021-2032)
  5. 11.2 Asia Platinum based Cancer Drug Market Size by Application
  6. 11.2.1 Asia Platinum based Cancer Drug Revenue by Application (2021-2032)
  7. 11.2.2 Asia Platinum based Cancer Drug Sales by Application (2021-2032)
  8. 11.2.3 Asia Platinum based Cancer Drug Price by Application (2021-2032)
  9. 11.3 Asia Platinum based Cancer Drug Market Size by Country
  10. 11.3.1 Asia Platinum based Cancer Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Platinum based Cancer Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Platinum based Cancer Drug Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Platinum based Cancer Drug Market Size by Type
  2. 12.1.1 SAMEA Platinum based Cancer Drug Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Platinum based Cancer Drug Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Platinum based Cancer Drug Price by Type (2021-2032)
  5. 12.2 SAMEA Platinum based Cancer Drug Market Size by Application
  6. 12.2.1 SAMEA Platinum based Cancer Drug Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Platinum based Cancer Drug Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Platinum based Cancer Drug Price by Application (2021-2032)
  9. 12.3 SAMEA Platinum based Cancer Drug Market Size by Country
  10. 12.3.1 SAMEA Platinum based Cancer Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Platinum based Cancer Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Platinum based Cancer Drug Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Platinum based Cancer Drug Value Chain Analysis
  2. 13.1.1 Platinum based Cancer Drug Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Platinum based Cancer Drug Production Mode & Process
  6. 13.2 Platinum based Cancer Drug Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Platinum based Cancer Drug Distributors
  9. 13.2.3 Platinum based Cancer Drug Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst